Clinical Trial Update: A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy [Phase 2]

View source ↗

Summary

A Phase 2 rollover trial update for Hepatitis C patients who were in the control arms of VX06-950-106, VX05-950-104 and VX05-950-104EU studies and did not respo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2011-07-25